Loading...
Accolade, Inc.
ACCD•NASDAQ
Healthcare
Medical - Healthcare Information Services
$7.02
$0.00(0.00%)
Accolade, Inc. (ACCD) Financial Performance & Income Statement Overview
Review Accolade, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
14.09%
↑ 14.09%
Operating Income Growth
-184.22%
↓ 184.22%
Net Income Growth
78.29%
↑ 78.29%
Operating Cash Flow Growth
60.28%
↑ 60.28%
Operating Margin
-41.29%
↓ 41.29%
Gross Margin
42.92%
↑ 42.92%
Net Profit Margin
-40.36%
↓ 40.36%
ROE
-44.61%
↓ 44.61%
ROIC
-33.91%
↓ 33.91%
Accolade, Inc. (ACCD) Income Statement & Financial Overview
Review Accolade, Inc.'s (ACCD) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $105.06M | $106.36M | $110.47M | $124.83M |
| Cost of Revenue | $58.57M | $56.92M | $69.003M | $70.50M |
| Gross Profit | $46.49M | $49.44M | $41.46M | $54.33M |
| Gross Profit Ratio | $0.44 | $0.46 | $0.38 | $0.44 |
| R&D Expenses | $20.59M | $22.48M | $26.31M | $24.19M |
| SG&A Expenses | $41.71M | $41.47M | $44.20M | $38.06M |
| Operating Expenses | $168.80M | $74.58M | $70.51M | $62.25M |
| Total Costs & Expenses | $227.38M | $131.50M | $139.51M | $132.75M |
| Interest Income | $1.45M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $1.61M |
| Depreciation & Amortization | $10.05M | $10.64M | $10.39M | $12.73M |
| EBITDA | -$15.81M | -$14.51M | -$18.66M | $3.41M |
| EBITDA Ratio | -$0.15 | -$0.14 | -$0.17 | $0.03 |
| Operating Income | -$122.31M | -$25.14M | -$29.05M | -$7.92M |
| Operating Income Ratio | -$1.16 | -$0.24 | -$0.26 | -$0.06 |
| Other Income/Expenses (Net) | $1.38M | $1.58M | $1.79M | $1.12M |
| Income Before Tax | -$120.93M | -$23.56M | -$27.26M | -$6.78M |
| Income Before Tax Ratio | -$1.15 | -$0.22 | -$0.25 | -$0.05 |
| Income Tax Expense | $332000.00 | $374000.00 | $335000.00 | $729000.00 |
| Net Income | -$121.26M | -$23.93M | -$27.59M | -$7.51M |
| Net Income Ratio | -$1.15 | -$0.23 | -$0.25 | -$0.06 |
| EPS | -$1.50 | -$0.30 | -$0.35 | -$0.10 |
| Diluted EPS | -$1.50 | -$0.30 | -$0.35 | -$0.10 |
| Weighted Avg Shares Outstanding | $80.65M | $80.07M | $78.12M | $77.35M |
| Weighted Avg Shares Outstanding (Diluted) | $80.65M | $80.07M | $78.12M | $77.35M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan